针刺治疗抑郁性神经症：多中心随机对照研究

目的：观察针刺对于抑郁性神经症的临床疗效。方法：采用多中心随机对照研究，将440例患者分为针刺组、百忧解组、非穴位针刺组。针刺组采用四关穴（合谷、太冲）为主的穴位，百忧解组服用药物百忧解20mg／d，非穴位针刺组患者接受针刺治疗，但取穴偏离真正的穴位。在治疗前、后进行汉密尔顿抑郁量表（HAMD）计分，按HAMD减分率进行疗效评价，以Asberg氏抗抑郁药副反应量表（SERS）结合严重不良反应记录进行安全性评估，对数据进行意向性分析（ITT分析）。结果：针刺组的总有效率为86．4％，优于非穴位针刺组的59．1％及百忧解组的72．7％；针刺组的HAMD计分与百忧解组相当，而且2组均优于非穴位针刺组；针刺组及非穴位针刺组的SERS计分均明显低于百忧解组，未见晕针等严重针刺不良反应记录。结论：针刺对于抑郁性神经症是一种有效、安全的疗法；针刺治疗抑郁性神经症的疗效可能优于百忧解或与百忧解相当，但副作用远低于百忧解。

Acupuncture for treatment of depressive neurosis: a multi-center randomized controlled study

OBJECTIVE: To observe the clinical therapeutic effect of acupuncture on depressive neurosis. METHODS: With a multi-center randomized controlled study, 440 cases were randomly divided into an acupuncture group, a prozac group, a non-acupoint needling group. In the acupuncture group, Hegu (LI 4) and Taichong (LR 3) were selected, and the Prozac group were treated with administration of 20 mg/d and the non-acupoint needling group were treated with needling the points deviating from the acupoints. The therapeutic effect was evaluated by HAMD score reduction rate, and Asberg's anti-depressant side-effect rating scale (SERS) and severe adverse reaction were used for safety evaluation, and the data were analyzed with ITT. RESULTS: The total effective rate was 86. 4% in the acupuncture group, which was better than 59.1% in the non-acupoint needling group and 72.7% in the prozac group; HAMD score in the acupuncture group was similar to that in the Prozac group, which was better than that in the non-acupoint needling group; the SERS scores in the acupuncture group and the non-acupoint needling group were significantly lower than that in the Prozac group, with no severe side-effects found for acupuncture. CONCLUSION: Acupuncture is an effective and safe therapy for depressive neurosis; therapeutic effect of acupuncture on depressive neurosis possibly is better than or similar to that of Prozac, but with less side-effects.